SeqOne is a next generation genomic analysis for next generation healthcare.
SeqOne Genomics has raised $22.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
SeqOne Genomics's investors include Bpifrance, Omnes Capital, Supernova Invest, Mérieux Equity Partners, Elaia.
SeqOne Genomics is headquartered in Montpellier, France.
SeqOne is a next generation genomic analysis for next generation healthcare.
SeqOne Genomics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SeqOne Genomics — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/seqone-genomics. Accessed July 19, 2026.
VCBacked. (2025). SeqOne Genomics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/seqone-genomics
{{cite web |title=SeqOne Genomics — Funding & Investors |url=https://www.vcbacked.co/company/seqone-genomics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated